Is type 2 diabetes related to leukoaraiosis? an updated review

Acta Neurologica Scandinavica

Volumn 132, Issue 3, 2015, Pages 147-155

  Del Bene, A ^a   Ciolli, L ^a   Borgheresi, L ^a   Poggesi, A ^a   Inzitari, D ^a   Pantoni, L ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

cerebrovascular diseases; diabetes; neurodegenerative disorders; neuroimaging; white matter changes

Indexed keywords

ALBUMIN; CREATININE; HEMOGLOBIN A1C; HOMOCYSTEINE; INSULIN;

AMINO ACID BLOOD LEVEL; CREATININE URINE LEVEL; DIFFUSION TENSOR IMAGING; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE MARKER; DISEASE SEVERITY; GLYCEMIC CONTROL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LEUKOARAIOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN URINE LEVEL; REVIEW; SYSTEMATIC REVIEW; VOLUMETRY; WHITE MATTER; AGED; BRAIN; COMPLICATION; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; MALE; MIDDLE AGED; NEUROIMAGING; PATHOLOGY; PSYCHOLOGY; RISK FACTOR; WHITE MATTER LESION;

AGED; BRAIN; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LEUKOARAIOSIS; MALE; MIDDLE AGED; NEUROIMAGING;

EID: 85006356889     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/ane.12398     Document Type: Review

References (72)

1. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010;9:689–701.
2. Inzitari D. Leukoaraiosis: an independent risk factor for stroke? Stroke 2003;34:2067–71.
3. Wardlaw JM, Smith EE, Biessels GJ et al. STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013;12:822–38.
4. Pantoni L, Garcia JH. The significance of cerebral white matter abnormalities 100 years after Binswanger's report. A review. Stroke 1995;26:1293–301.
5. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010;341:c3666.
6. LADIS Study Group. 2001–2011: a decade of the LADIS (Leukoaraiosis And DISability) Study: what have we learned about white matter changes and small-vessel disease? Cerebrovasc Dis 2011;32:577–88.
7. Chowdhury MH, Nagai A, Bokura H, Nakamura E, Kobayashi S, Yamaguchi S. Age-related changes in white matter lesions, hippocampal atrophy, and cerebral microbleeds in healthy subjects without major cerebrovascular risk factors. J Stroke Cerebrovasc Dis 2011;20:302–9.
8. de Leeuw FE, de Groot JC, Oudkerk M et al. Hypertension and cerebral white matter lesions in a prospective cohort study. Brain 2002;125:765–72.
9. Murray AD, Staff RT, Shenkin SD, Deary IJ, Starr JM, Whalley LJ. Brain white matter hyperintensities: relative importance of vascular risk factors in nondemented elderly people. Radiology 2005;237:251–7.
10. Firbank MJ, Wiseman RM, Burton EJ, Saxby BK, O'brien JT, Ford GA. Brain atrophy and white matter hyperintensity change in older adults and relationship to blood pressure. Brain atrophy, WMH change and blood pressure. J Neurol 2007;254:713–21.
11. Sheetz MJ, King GL. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 2002;288:2579–88.
12. Aboyans V, Lacroix P, Criqui MH. Large and small vessels atherosclerosis: similarities and differences. Prog Cardiovasc Dis 2007;50:112–25.
13. Girach A, Manner D, Porta M. Diabetic microvascular complications: can patients at risk be identified? A review Int J Clin Pract 2006;60:1471–83.
14. International Diabetes Federation. The global burden. http://www.idf.org/diabetesatlas. Last accessed 28 April 2014.
15. Marshall SM, Flyvbjerg A. Prevention and early detection of vascular complications of diabetes. BMJ 2006;333:475–80.
16. Das AK, Seshiah V, Sahay BK et al. Improving management practices and clinical outcomes in type 2 diabetes study: Prevalence of complications in people with type 2 diabetes in India. Indian J Endocrinol Metab 2012;16:S430–1.
17. Cameron NE, Eaton SE, Cotter MA, Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 2001;44:1973–88.
18. McCrimmon RJ, Ryan CM, Frier BM. Diabetes and cognitive dysfunction. Lancet 2012;379:2291–9.
19. Verdelho A, Madureira S, Moleiro C et al. White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study. Neurology 2010;75:160–7.
20. van Harten B, de Leeuw FE, Weinstein HC, Scheltens P, Biessels GJ. Brain imaging in patients with diabetes: a systematic review. Diabetes Care 2006;29:2539–48.
21. Manschot SM, Biessels GJ, de Valk H et al. Utrecht Diabetic Encephalopathy Study Group. Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes. Diabetologia 2007;50:2388–97.
22. Van Harten B, Oosterman JM, Potter Van Loon BJ, Scheltens P, Weinstein HC. Brain lesions on MRI in elderly patients with type 2 diabetes mellitus. Eur Neurol 2007;57:70–4.
23. Anan F, Masaki T, Iwao T et al. The role of microalbuminuria and insulin resistance as significant risk factors for white matter lesions in Japanese type 2 diabetic patients. Curr Med Res Opin 2008;24:1561–7.
24. Ichikawa H, Takahashi N, Mukai M, Akizawa T, Kawamura M. Asymptomatic large T2 high-signal pontine lesions that are different from ischemic rarefaction. J Stroke Cerebrovasc Dis 2008;17:394–400.
25. Yau PL, Javier D, Tsui W et al. Emotional and neutral declarative memory impairments and associated white matter microstructural abnormalities in adults with type 2 diabetes. Psychiatry Res 2009;174:223–30.
26. Saczynski JS, Siggurdsson S, Jonsson PV et al. Glycemic status and brain injury in older individuals: the age gene/environment susceptibility-Reykjavik study. Diabetes Care 2009;32:1608–13.
27. Imamine R, Kawamura T, Umemura T et al. Does cerebral small vessel disease predict future decline of cognitive function in elderly people with type 2 diabetes? Diabetes Res Clin Pract 2011;94:91–9.
28. Hsu JL, Chen YL, Leu JG et al. Microstructural white matter abnormalities in type 2 diabetes mellitus: a diffusion tensor imaging study. NeuroImage 2012;59:1098–105.
29. Falvey CM, Rosano C, Simonsick EM et al. Macro- and microstructural magnetic resonance imaging indices associated with diabetes among community-dwelling older adults. Diabetes Care 2013;36:677–82.
30. Yao H, Takashima Y, Hashimoto M, Uchino A, Yuzuriha T. Subclinical cerebral abnormalities in chronic kidney disease. Contrib Nephrol 2013;179:24–34.
31. Reijmer YD, Brundel M, De Bresser J, Kappelle LJ, Leemans A, Biessels GJ. Microstructural white matter abnormalities and cognitive functioning in type 2 diabetes: a diffusion tensor imaging study. Diabetes Care 2013;36:137–44.
32. Espeland MA, Bryan RN, Goveas JS et al. Influence of type 2 diabetes on brain volumes and changes in brain volumes: results from the Women's Health Initiative Magnetic Resonance Imaging studies. Diabetes Care 2013;36:90–7.
33. Minn YK, Suk SH, Park H et al. Tooth loss is associated with brain white matter change and silent infarction among adults without dementia and stroke. J Korean Med Sci 2013;28:929–33.
34. Scheltens P, Barkhof F, Leys D et al. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 1993;114:7–12.
35. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. Am J Roentgenol 1987;149:351–6.
36. Knopman DS, Mosley TH Jr, Bailey KR, Jack CR Jr, Schwartz GL, Turner ST. Associations of microalbuminuria with brain atrophy and white matter hyperintensities in hypertensive sibships. J Neurol Sci 2008;271:53–60.
37. Tiehuis AM, van der Graaf Y, Visseren FL et al. Diabetes increases atrophy and vascular lesions on brain MRI in patients with symptomatic arterial disease. Stroke 2008;39:1600–3.
38. Yau PL, Javier DC, Ryan CM et al. Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus. Diabetologia 2010;53:2298–306.
39. Park JH, Ryoo S, Kim SJ et al. Differential risk factors for lacunar stroke depending on the MRI (white and red) subtypes of microangiopathy. PLoS ONE 2012;7:e44865.
40. Ben-Assayag E, Mijajlovic M, Shenhar-Tsarfaty S, Bova I, Shopin L, Bornstein NM. Leukoaraiosis is a chronic atherosclerotic disease. Sci World J 2012;2012:532141.
41. Gouw AA, van der Flier WM, Fazekas F et al. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study. Stroke 2008;39:1414–20.
42. Cheng CY, Tsai CF, Wang SJ, Hsu CY, Fuh JL. Sleep disturbance correlates with white matter hyperintensity in patients with subcortical ischemic vascular dementia. J Geriatr Psychiatry Neurol 2013;26:158–64.
43. Prins ND, van Straaten EC, van Dijk EJ et al. Measuring progression of cerebral white matter lesions on MRI: visual rating and volumetrics. Neurology 2004;62:1533–9.
44. Last D, Alsop DC, Abduljalil AM et al. Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity. Diabetes Care 2007;30:1193–9.
45. Korf ES, White LR, Scheltens P, Launer LJ. Brain aging in very old men with type 2 diabetes: the Honolulu-Asia Aging Study. Diabetes Care 2006;29:2268–74.
46. Ropele S, Enzinger C, Sollinger M et al. The impact of sex and vascular risk factors on brain tissue changes with aging: magnetization transfer imaging results of the Austrian stroke prevention study. AJNR Am J Neuroradiol 2010;31:1297–301.
47. Basile AM, Pantoni L, Pracucci G et al. Age, hypertension, and lacunar stroke are the major determinants of the severity of age-related white matter changes. The LADIS (Leukoaraiosis and Disability in the Elderly) Study. Cerebrovasc Dis 2006;21:315–22.
48. Akisaki T, Sakurai T, Takata T et al. Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT). Diabetes Metab Res Rev 2006;22:376–84.
49. Kumar R, Anstey KJ, Cherbuin N, Wen W, Sachdev PS. Association of type 2 diabetes with depression, brain atrophy, and reduced fine motor speed in a 60- to 64-year-old community sample. Am J Geriatr Psychiatry 2008A;16:989–98.
50. Kumar A, Haroon E, Darwin C et al. Gray matter prefrontal changes in type 2 diabetes detected using MRI. J Magn Reson Imaging 2008B;27:14–9.
51. Wada M, Nagasawa H, Iseki C et al. Cerebral small vessel disease and chronic kidney disease (CKD): results of a cross-sectional study in community-based Japanese elderly. J Neurol Sci 2008;272:36–42.
52. Han JH, Wong KS, Wang YY, Fu JH, Ding D, Hong Z. Plasma level of sICAM-1 is associated with the extent of white matter lesion among asymptomatic elderly subjects. Clin Neurol Neurosurg 2009;111:847–51.
53. de Bresser J, Tiehuis AM, van den Berg E et al. Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes. Diabetes Care 2010;33:1309–14.
54. Saji N, Shimizu H, Kawarai T, Tadano M, Kita Y, Yokono K. Increased brachial-ankle pulse wave velocity is independently associated with white matter hyperintensities. Neuroepidemiology 2011;36:252–7.
55. Knopman DS, Penman AD, Catellier DJ et al. Vascular risk factors and longitudinal changes on brain MRI: the ARIC study. Neurology 2011;76:1879–85.
56. Laugesen E, Høyem P, Stausbøl-Grøn B et al. Carotid-femoral pulse wave velocity is associated with cerebral white matter lesions in type 2 diabetes. Diabetes Care 2013;36:722–8.
57. Moran C, Phan TG, Chen J et al. Brain Atrophy in Type 2 Diabetes: Regional distribution and influence on cognition. Diabetes Care 2013;36:4036–42.
58. Khan U, Porteous L, Hassan A, Markus HS. Risk factor profile of cerebral small vessel disease and its subtypes. J Neurol Neurosurg Psychiatry 2007;78:702–6.
59. Kim BJ, Lee SH, Kang BS, Yoon BW, Roh JK. Diabetes increases large artery diseases, but not small artery diseases in the brain. J Neurol 2008;255:1176–81.
60. Staekenborg SS, van Straaten EC, van der Flier WM, Lane R, Barkhof F, Scheltens P. Small vessel versus large vessel vascular dementia: risk factors and MRI findings. J Neurol 2008;255:1644–51.
61. Masugata H, Senda S, Goda F et al. Cardiac diastolic dysfunction is associated with cerebral white matter lesions in elderly patients with risk factors for atherosclerosis. Tohoku J Exp Med 2008;216:99–108.
62. Putaala J, Kurkinen M, Tarvos V, Salonen O, Kaste M, Tatlisumak T. Silent brain infarcts and leukoaraiosis in young adults with first-ever ischemic stroke. Neurology 2009;72:1823–9.
63. van Elderen SG, de Roos A, de Craen AJ et al. Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up. Neurology 2010;75:997–1002.
64. Puskas JD, Stringer A, Hwang SN et al. Neurocognitive and neuroanatomic changes after off-pump versus on-pump coronary artery bypass grafting: long-term follow-up of a randomized trial. J Thorac Cardiovasc Surg 2011;141:1116–27.
65. Heliopoulos I, Artemis D, Vadikolias K, Tripsianis G, Piperidou C, Tsivgoulis G. Association of ultrasonographic parameters with subclinical white-matter hyperintensities in hypertensive patients. Cardiovasc Psychiatry Neurol 2012;2012:616572.
66. Reinhard H, Garde E, Skimminge A et al. Plasma NT-proBNP and white matter hyperintensities in type 2 diabetic patients. Cardiovasc Diabetol 2012;11:119.
67. Kooistra M, Geerlings MI, Mali WP, Vincken KL, Van Der Graaf Y, Biessels GJ. Diabetes mellitus and progression of vascular brain lesions and brain atrophy in patients with symptomatic atherosclerotic disease. The SMART-MR study. J Neurol Sci 2013;332:69–74.
68. Biessels GJ, Koffeman A, Scheltens P. Diabetes and cognitive impairment. Clinical diagnosis and brain imaging in patients attending a memory clinic. J Neurol 2006A;253:477–82.
69. Biessels GJ, de Leeuw FE, Lindeboom J, Barkhof F, Scheltens P. Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitus. J Neurol Neurosurg Psychiatry 2006B;77:304–7.
70. Kotagal V, Albin RL, Müller ML, Koeppe RA, Frey KA, Bohnen NI. Diabetes is associated with postural instability and gait difficulty in Parkinson disease. Parkinsonism Relat Disord 2013;19:522–6.
71. Exalto LG, van der Flier WM, Scheltens P, Vrenken H, Biessels GJ. Dysglycemia, brain volume and vascular lesions on MRI in a memory clinic population. J Diabetes Complications 2014;28:85–90.
72. Weiner MF, de la Plata CM, Fields BA et al. Brain MRI, apoliprotein E genotype, and plasma homocysteine in American Indian Alzheimer disease patients and Indian controls. Curr Alzheimer Res 2009;6:52–8.